Literature DB >> 18289887

CCN family 2/connective tissue growth factor (CCN2/CTGF) stimulates proliferation and differentiation of auricular chondrocytes.

T Fujisawa1, T Hattori, M Ono, J Uehara, S Kubota, T Kuboki, M Takigawa.   

Abstract

OBJECTIVES: CCN family 2/connective tissue growth factor (CCN2/CTGF) is an atypical growth factor for growth plate chondrocytes. It plays an important role in their proliferation and differentiation in vitro, but does not stimulate hypertrophy or calcification of articular chondrocytes. We herein report for the first time that CCN2/CTGF promotes growth and differentiation of auricular chondrocytes and maintains their molecular phenotype in vitro and in vivo.
METHODS: Auricular chondrocytes were isolated from rabbit auricular cartilage by trypsin-collagenase treatment, and treated with human recombinant CCN2/CTGF or infected with adenovirus harboring the ccn2/ctgf gene. Cell proliferation was measured by [(3)H] thymidine incorporation and MTS assay, and changes in gene expression of auricular chondrocyte markers were monitored by real-time polymerase chain reaction, Northern hybridization, and histological analysis. For in vivo studies, auricular chondrocytes were cultured as pellets and implanted subcutaneously after treatment of recombinant human CCN2/CTGF. Ectopically formed cartilage was subjected to histological analysis. Cell death was monitored by in situ TUNEL analysis.
RESULTS: CCN2/CTGF stimulated proliferation, differentiation and synthesis of elastin and proteoglycans of rabbit primary auricular chondrocytes in a dose-dependent manner. CCN2/CTGF caused a 2.5-fold increase in the expression of elastin in comparison to the control, resulting in enhanced deposition of elastin fibers in a monolayer culture of auricular chondrocytes. Mineralization was not induced; in contrast, CCN2/CTGF stimulated expression of matrix gla protein which is known to impair mineralization. Furthermore, pretreatment of pellets of auricular chondrocytes with CCN2/CTGF and subcutaneous implantation significantly enhanced the growth of ectopic auricular cartilage pieces expressing phenotypic markers of auricular chondrocytes including type II and X collagen. Notably, chondrocyte apoptosis was impaired by CCN2/CTGF.
CONCLUSIONS: These findings show that CCN2/CTGF may be a suitable agent for promoting differentiation and growth of auricular chondrocytes, while preventing mineralization and apoptosis, and suggests that CCN2/CTGF may be useful for the repair or reconstruction of elastic cartilage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18289887     DOI: 10.1016/j.joca.2007.11.001

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  19 in total

1.  Prostaglandin E2 regulates the expression of connective tissue growth factor (CTGF/CCN2) in human osteoarthritic chondrocytes via the EP4 receptor.

Authors:  Kayo Masuko; Minako Murata; Kazuo Yudoh; Hiroyuki Shimizu; Moroe Beppu; Hiroshi Nakamura; Tomohiro Kato
Journal:  BMC Res Notes       Date:  2010-01-15

2.  Recombinant human midkine stimulates proliferation of articular chondrocytes.

Authors:  Z H Zhang; H X Li; Y P Qi; L J Du; S Y Zhu; M Y Wu; H L Lu; Y Yu; W Han
Journal:  Cell Prolif       Date:  2010-04       Impact factor: 6.831

Review 3.  Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases.

Authors:  Minyang Fu; Dandan Peng; Tianxia Lan; Yuquan Wei; Xiawei Wei
Journal:  Acta Pharm Sin B       Date:  2022-01-19       Impact factor: 14.903

4.  The role of tumor cell-derived connective tissue growth factor (CTGF/CCN2) in pancreatic tumor growth.

Authors:  Kevin L Bennewith; Xin Huang; Christine M Ham; Edward E Graves; Janine T Erler; Neeraja Kambham; Jonathan Feazell; George P Yang; Albert Koong; Amato J Giaccia
Journal:  Cancer Res       Date:  2009-02-01       Impact factor: 12.701

5.  Role of ADAMTS-12 in Protecting Against Inflammatory Arthritis in Mice By Interacting With and Inactivating Proinflammatory Connective Tissue Growth Factor.

Authors:  Jian-Lu Wei; Wenyu Fu; Aubryanna Hettinghouse; Wen-Jun He; Kenneth E Lipson; Chuan-Ju Liu
Journal:  Arthritis Rheumatol       Date:  2018-09-24       Impact factor: 10.995

6.  Silencing SATB1 inhibits proliferation of human osteosarcoma U2OS cells.

Authors:  Haiying Zhang; Shanshan Qu; Shuang Li; Yang Wang; Yulin Li; Yimin Wang; Zonggui Wang; Ronggui Li
Journal:  Mol Cell Biochem       Date:  2013-03-21       Impact factor: 3.396

7.  The role of CCN2 in cartilage and bone development.

Authors:  Satoshi Kubota; Masaharu Takigawa
Journal:  J Cell Commun Signal       Date:  2011-02-14       Impact factor: 5.782

8.  CCN family member 2/connective tissue growth factor (CCN2/CTGF) has anti-aging effects that protect articular cartilage from age-related degenerative changes.

Authors:  Shinsuke Itoh; Takako Hattori; Nao Tomita; Eriko Aoyama; Yasutaka Yutani; Takashi Yamashiro; Masaharu Takigawa
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

9.  CCN2: a master regulator of the genesis of bone and cartilage.

Authors:  Masaharu Takigawa
Journal:  J Cell Commun Signal       Date:  2013-08       Impact factor: 5.782

10.  Cartilage-specific over-expression of CCN family member 2/connective tissue growth factor (CCN2/CTGF) stimulates insulin-like growth factor expression and bone growth.

Authors:  Nao Tomita; Takako Hattori; Shinsuke Itoh; Eriko Aoyama; Mayumi Yao; Takashi Yamashiro; Masaharu Takigawa
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.